- Sputnik International
The latest news and stories from Russia. Stay tuned for updates and breaking news on defense, politics, economy and more.

Global #SputnikV COVID-19 Vaccine Campaign Goes Live on Social Media

© Sputnik / Georgy Zimarev / Go to the mediabankSputnik V Vaccine
Sputnik V Vaccine - Sputnik International
The Russian Direct Investment Fund (RDIF), the nation's sovereign wealth fund, and the Gamaleya National Centre for Microbiology and Epidemiology, supported by international partners, are launching a campaign across all major social media platforms to provide up-to-date information and raise awareness about the Russian vaccine around the world.

The social media campaign, which will use the #SputnikV hashtag, will focus on the progress of #SputnikV clinical trials, production, and mass vaccination in different countries. During the campaign, scientists from the Gamaleya Centre will tell the story behind the technology and creation of the #SputnikV vaccine, while people who received the #SputnikV inoculation will share their personal experiences and thoughts.

A researcher works inside a laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology where the world's first coronavirus vaccine registered in Russia was developed, in Moscow, Russia. On August 11, Russia announced registering the world's first coronavirus vaccine, dubbed Sputnik V, set to be produced industrially.  - Sputnik International
Russia's Biocad Plans to Set Up Technology for Sputnik V Vaccine Production by December

#SputnikV social media channels will also become the main platform for the exclusive delivery of major news about the vaccine, publication of the latest data on the number of people vaccinated, and vaccine production data. The channels will also carry live events with major announcements and expert commentaries. Information about #SputnikV will be available on the following platforms:





#SputnikV is the world's first registered vaccine and is based on a well-studied human adenoviral vector-based platform. It currently ranks among the top 10 candidate vaccines approaching the end of clinical trials and the start of mass production on the World Health Organisation's (WHO) list. Russia submitted applications to the WHO for accelerated registration and prequalification of #SputnikV.

The ongoing #SputnikV post-registration clinical trial in Russia involves 40,000 volunteers. Clinical trials of #SputnikV have been announced in the UAE, India, Venezuela, and Belarus. 

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, noted:

"Our social media campaign will focus on providing up-to-date information about our vaccine effort for a global audience but beyond that it also aims to give mankind hope that they will soon be able to break free from the COVID-19 pandemic and go back to normal life without lockdowns and face masks. In this life people will again be able to meet friends, go out to museums, theatres, and restaurants as well as travel to different countries. Businesses will again stay open providing jobs that guarantee well-being for employees and their families. We invite all people in different countries to join our campaign and support our #SputnikV vaccine effort".

The Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. The RDIF acts as a catalyst for direct investment in the Russian economy. RDIF's management company is based in Moscow. Currently, the RDIF has been successful in jointly implementing more than 80 projects with foreign partners, totalling more than 1.9 trillion roubles, and covering 95% of the Russian Federation's regions. RDIF portfolio companies employ more than 800,000 people and generate revenues that equate to more than 6% of Russia's GDP. The RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries worth more than $40 billion. Further information can be found at rdif.ru

For additional information contact:

Arseniy Palagin                                        Andrew Leach / Maria Shiryaevskaya

Russian Direct Investment Fund                        Hudson Sandler

Press Secretary                                          Tel: +44 (0) 20 7796 4133

Tel: +7 495 644 34 14, ext. 2395

Mobile: +7 916 110 31 41

E-mail: arseniy.palagin@rdif.ru

To participate in the discussion
log in or register
Заголовок открываемого материала